| Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis |
| Author(s): Prentice M1, Mpima S2, Martinez S2, Nasuti P2, Davda R1, Payne H1 |
| Affiliations(s): 1 University College Hospital, London, UK, 2 IQVIA , London, UK |
| Publication(s): |
| Document Type(s): |
| Countries: Asia Pacific, Europe, |
C:
Y: |
2018 |
|
L:
A: |
English
|
|
 |
| |
| |
| Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia |
| Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 |
| Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA |
Publication(s): JCO ( ASCO 2018)
|
| Document Type(s): Abstract, |
| Countries: Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK, |
| Click here for the abstract |
C:
Y: |
Oncology,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| EVALUATING NSCLC TREATMENT OPTIONS USING REAL WORLD DATA: FINDINGS FROM AN ONCOLOGY SURVEY ACROSS EIGHT COUNTRIES |
| Author(s): Takeno S1, Tanaka S1, Saijo N1 Nasuti P2 |
| Affiliations(s): 1IQVIA Solutions Japan K.K., Tokyo, Japan, 2IQVIA , London, UK |
Publication(s): ISPOR 2018 APAC
|
| Document Type(s): Poster, |
| Countries: Asia Pacific, Europe, |
C:
Y: |
Oncology,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| High Prevalence of Comorbidities and Contraindicated Medications in Hepatitis C Patients in Japan |
| Author(s): Tsutsumi, T., Kruger, E., Tan, S. C., Yotsuyanagi, H. |
| Affiliations(s): QuintilesIMS Health Singapore |
Publication(s): Journal of Viral Hepatitis
|
| Document Type(s): Article, |
| Countries: Asia Pacific, |
C:
Y: |
Infectious disease,
2017 |
|
L:
A: |
English
|
|
|
| |
| |
| Evaluating Renal Cell Carcinoma treatment options using real world data: findings from an oncology survey across seven countries |
| Author(s): S. Mpima, S. Menon, P. Nasuti, H. Mistry |
| Affiliations(s): IQVIA London UK |
Publication(s): ESMO - ImmunoOncology
|
| Document Type(s): Poster, |
| Countries: Asia Pacific, Europe, |
C:
Y: |
Oncology,
2017 |
|
L:
A: |
English
|
|
|
| |
| |
| Real-world evidence in Asia Pacific: Are we ready? Challenges and novel
approaches to generating evidence in the absence of real-world data |
| Author(s): Willford J1, Eggleston A2, Caputo J1 |
| Affiliations(s): 1 IMS Health Asia Pacific, Singapore 2 Sanofi, Singapore |
Publication(s): ISPOR 17th Annual European Congress, 8th ? 12th November 2014, Amsterdam
|
| Document Type(s): Symposium, |
| Countries: Asia Pacific, |
C:
Y: |
Methodology,
2014 |
|
L:
A: |
English
Real World Data, |
|
|
| |
| |
| Real-world evidence in Asia-Pacific: are we ready? Challenges and novel approaches to generating evidence in the absence of real-world data |
| Author(s): Willford J1, Eggleston A2, Caputo J1 |
| Affiliations(s): 1 IMS Health Asia Pacific, Singapore 2 Sanofi, Singapore |
Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
|
| Document Type(s): Poster, |
| Countries: Asia Pacific, |
C:
Y: |
Methodology,
2014 |
|
L:
A: |
English
Real World Evidence, |
|
|
| |
| |
| Envisioning oncology coverage decision framework: how do current and future trends in Asia-Pacific affect the accessibility? |
| Author(s): Leartsakulpanitch J1, Chiu C-F2, Bae SJ3, Tan SC4 |
| Affiliations(s): 1 Johnson & Johnson, Bangkok, Thailand 2 China Medical University Hospital, Taipei, Taiwan 3 Ewha Womans University, Seoul, South Korea 4 IMS Asia Pacific, Singapore, Singapore |
Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
|
| Document Type(s): Symposium, |
| Countries: Asia Pacific, |
C:
Y: |
Oncology,
2014 |
|
L:
A: |
English
Methodology, |
|
|
| |
| |
| Understanding treatment in metastatic castrate-resistant prostate cancer: Implications of variance between UK and Asia |
| Author(s): King C |
| Affiliations(s): IMS Health Asia-Pac & China, Singapore |
Publication(s): AccessPoint, 2014, May; 4(8): 36-39
|
| Document Type(s): Article, |
| Countries: Asia Pacific, UK, |
| Click here for the abstract |
C:
Y: |
Oncology,
2014 |
|
L:
A: |
English
Real World Evidence, |
|
|
| |
| |
| High-value oncology targeted therapies: Opportunities and challenges in emerging Asia Pacific markets |
| Author(s): Afable A, Caputo J |
| Affiliations(s): IMS Health, Asia-Pac, Singapore, Singapore |
Publication(s): AccessPoint, 2014, May; 4(8): 46-50
|
| Document Type(s): Article, |
| Countries: Asia Pacific, |
| Click here for the abstract |
C:
Y: |
Oncology, Pricing and reimbursement,
2014 |
|
L:
A: |
English
Real World Evidence, |
|
|
| |
| |
 1 of 2 
|
